Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Liposomal vitamin C** is a formulation of ascorbic acid (vitamin C) encapsulated within liposomes—microscopic lipid bilayer vesicles—designed to improve the gastrointestinal stability, absorption, and cellular uptake of vitamin C compared to standard, non-liposomal formulations[1][3][5]. The encapsulation protects vitamin C from degradation in the digestive tract and enables more efficient delivery into plasma and leukocytes, with evidence showing significantly increased bioavailability and higher peak levels versus regular vitamin C[1][5]. Mechanistically, it provides the same biological effects as vitamin C: supporting collagen synthesis, antioxidant defense, immune system functionality, neurotransmitter synthesis, and cardiovascular health[2][3][4]. Liposomal vitamin C is used orally, primarily as a dietary supplement to support overall health, immune function, and as an adjunct in conditions of vitamin C deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on liposomal vitamin c.